casino games with free sign up bonus

WASHINGTON (AP) — President-elect Donald Trump has selected former White House aide Brooke Rollins to lead the Department of Agriculture in his second administration. Here are some things to know about Trump’s choice and the agency that Rollins would lead if she is confirmed by the Senate. Rollins, 52, graduated from Texas A&M University with an undergraduate degree in agricultural development before completing law school at the University of Texas. She served as domestic policy chief during Trump's first term, a portfolio that included agricultural policy. After leaving the White House, she became president and CEO of the America First Policy Institute, a group helping to lay the groundwork for a second Trump administration. Over the years, Rollins has forged a strong enough relationship with Trump, who has prized proven loyalty in his Cabinet and top adviser picks , that she was among the people floated as a potential White House chief of staff. That job went to Susie Wiles, Trump's co-campaign manager. Rollins, in an interview earlier this year, called Trump an “amazing boss.” President Abraham Lincoln founded the USDA in 1862, when about half of all Americans lived on farms. The sprawling department now reaches into every American neighborhood, grocery store and school cafeteria. The USDA is the primary agency overseeing the nation’s farming, forestry, ranching, food quality and nutrition. The agency has a dual purpose of promoting and regulating agriculture practice and products. The agency oversees multiple support programs for farmers; animal and plant health; and the safety of meat, poultry and eggs that anchor the nation’s food supply. Its federal nutrition programs provide food to low-income people, pregnant women and young children. And the department sets standards for school meals. Trump did not offer many specifics about his agriculture policies during the campaign. But if he keeps his pledge to impose sweeping tariffs, farmers could be affected quickly — and potentially harshly. During the first Trump administration, countries like China responded to Trump’s tariffs by imposing retaliatory tariffs on U.S. exports like the corn and soybeans routinely sold overseas. Trump countered by offering massive multibillion-dollar aid to farmers to help them weather the trade war. The ripple effects could extend to consumers’ grocery bills, as well. When things are going smoothly, agriculture secretaries are not usually prominent faces of an administration. But when the nation’s food supply is at issue, it could be another story. Gomez Licon reported from Fort Lauderdale, Florida.casino games with free sign up bonus 。

Palo Alto Networks ( NASDAQ:PANW – Get Free Report ) had its target price increased by stock analysts at Robert W. Baird from $425.00 to $435.00 in a note issued to investors on Thursday. The firm presently has an “outperform” rating on the network technology company’s stock. Robert W. Baird’s price objective points to a potential upside of 13.47% from the stock’s previous close. Other equities analysts have also recently issued research reports about the company. Truist Financial raised their price target on Palo Alto Networks from $400.00 to $425.00 and gave the company a “buy” rating in a report on Monday, November 18th. Needham & Company LLC lifted their price target on shares of Palo Alto Networks from $385.00 to $450.00 and gave the stock a “buy” rating in a research report on Thursday. Sanford C. Bernstein boosted their price target on shares of Palo Alto Networks from $364.00 to $399.00 and gave the stock an “outperform” rating in a research note on Tuesday, August 20th. Bank of America raised their price objective on shares of Palo Alto Networks from $400.00 to $430.00 and gave the company a “neutral” rating in a research note on Thursday. Finally, Scotiabank upped their target price on shares of Palo Alto Networks from $385.00 to $400.00 and gave the company a “sector outperform” rating in a research report on Tuesday, August 20th. Two equities research analysts have rated the stock with a sell rating, ten have issued a hold rating, thirty-one have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $402.03. Check Out Our Latest Stock Analysis on PANW Palo Alto Networks Stock Down 3.6 % Palo Alto Networks shares are scheduled to split before the market opens on Monday, December 16th. The 2-1 split was announced on Wednesday, November 20th. The newly issued shares will be payable to shareholders after the market closes on Friday, December 13th. Palo Alto Networks ( NASDAQ:PANW – Get Free Report ) last posted its quarterly earnings data on Wednesday, November 20th. The network technology company reported $1.56 earnings per share for the quarter, topping the consensus estimate of $1.48 by $0.08. The firm had revenue of $2.14 billion during the quarter, compared to analysts’ expectations of $2.12 billion. Palo Alto Networks had a net margin of 32.11% and a return on equity of 26.83%. Palo Alto Networks’s revenue was up 13.9% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.63 EPS. As a group, equities analysts predict that Palo Alto Networks will post 3.56 earnings per share for the current fiscal year. Insider Activity at Palo Alto Networks In other Palo Alto Networks news, CEO Nikesh Arora sold 81,586 shares of the stock in a transaction on Thursday, October 10th. The shares were sold at an average price of $367.99, for a total value of $30,022,832.14. Following the completion of the sale, the chief executive officer now owns 618,715 shares in the company, valued at $227,680,932.85. This trade represents a 11.65 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link . Also, EVP Nir Zuk sold 36,000 shares of the business’s stock in a transaction dated Tuesday, October 1st. The stock was sold at an average price of $332.50, for a total transaction of $11,970,000.00. Following the transaction, the executive vice president now owns 1,115,567 shares in the company, valued at $370,926,027.50. This represents a 3.13 % decrease in their ownership of the stock. The disclosure for this sale can be found here . Over the last quarter, insiders have sold 254,252 shares of company stock valued at $89,041,637. 2.50% of the stock is owned by insiders. Institutional Trading of Palo Alto Networks Several institutional investors and hedge funds have recently bought and sold shares of PANW. Mainstream Capital Management LLC acquired a new position in Palo Alto Networks in the 3rd quarter valued at about $1,156,000. Alpha Cubed Investments LLC grew its position in shares of Palo Alto Networks by 16.4% in the third quarter. Alpha Cubed Investments LLC now owns 231,566 shares of the network technology company’s stock valued at $79,149,000 after purchasing an additional 32,626 shares during the last quarter. Handelsbanken Fonder AB increased its stake in shares of Palo Alto Networks by 3.8% during the third quarter. Handelsbanken Fonder AB now owns 196,700 shares of the network technology company’s stock worth $67,232,000 after purchasing an additional 7,291 shares during the period. Harvest Portfolios Group Inc. acquired a new stake in Palo Alto Networks during the 3rd quarter worth approximately $24,414,000. Finally, Parsons Capital Management Inc. RI lifted its holdings in Palo Alto Networks by 4.5% during the 2nd quarter. Parsons Capital Management Inc. RI now owns 2,695 shares of the network technology company’s stock worth $914,000 after purchasing an additional 116 shares during the last quarter. Institutional investors own 79.82% of the company’s stock. About Palo Alto Networks ( Get Free Report ) Palo Alto Networks, Inc provides cybersecurity solutions worldwide. The company offers firewall appliances and software; and Panorama, a security management solution for the global control of network security platform as a virtual or a physical appliance. It also provides subscription services covering the areas of threat prevention, malware and persistent threat, URL filtering, laptop and mobile device protection, DNS security, Internet of Things security, SaaS security API, and SaaS security inline, as well as threat intelligence, and data loss prevention. Featured Articles Receive News & Ratings for Palo Alto Networks Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Palo Alto Networks and related companies with MarketBeat.com's FREE daily email newsletter .

Gisele Bündchen & Ex Tom Brady Share Birthday Tributes to Son Benjamin

In January, 2024, Bret Stephens writing in the NYTimes attempted to understand the issues that the United States was facing in this presidential election year. “As writers like Tablet’s Alana Newhouse have noted, brokenness has become the defining feature of much of American life: broken families, broken public schools, broken small towns and inner cities, broken universities, broken health care, broken media, broken churches, broken borders, broken government. At best, they have become shells of their former selves.” He could have also included broken concepts of our own history. There are many times we have had to confront the brokenness of our own past, and we will continue to face these challenges, but we should remember those who endured incredible hardships to give us the institutions and the ideals that helped create this country...and not allow them to “become shells of their former selves.” With so many broken areas in our society, what should we celebrate and be thankful for this Thanksgiving? We might begin to recover some realistic view of our history by reading the story of John Smith, the English soldier, explorer, Governor of the Jamestown colony in Virginia and the man who gave the name New England to the area where the Pilgrims would land in 1620. Having gone to sea at the age of 16 to seek his fortune, he had served as a mercenary soldier for France, Holland, and Austria before he was captured and sent as an enslaved gift to a woman in Constantinople. Smith killed his slavemaster who beat him regularly and escaped to return to England in 1604. This was all before he began his adventure in 1607 in Jamestown, Virginia, where starvation and political infighting awaited him causing him to issue the Biblical decree that “he who will not work, neither shall he eat.” Or we might look at the life of William Bradford, (1590 – 1657) who led the Pilgrims from England to New England in 1620, after a 12 year stay in Holland. Bradford became an orphan at the age of seven and was sent to live with two uncles. He later noted in his journal that he suffered from a "long sickness" and was unable to work, but he began reading the Bible and great works of literature. Some historians have suggested this was a key factor in his adopting the Separatist branch of Puritan theology. Bradford would become the main force behind the writing of the Mayflower Compact which bound the Pilgrims to “live by the laws they enacted” because they had landed in New England, further to the north than their charter allowed. “In the name of God, Amen, Having undertaken for the Glory of God, and Advancement of the Christian Faith, and the Honour of our King and Country, a Voyage to plant the first Colony in the northern Parts of Virginia; Do by these Presents, solemnly and mutually, in the Presence of God and one another, covenant and combine ourselves together into a civil Body Politick, for our better Ordering and Preservation, and Furtherance of the Ends aforesaid: And by Virtue hereof do enact, constitute, and frame, such just and equal Laws, Ordinances, Acts, Constitutions, and Offices, from time to time, as shall be thought most meet and convenient for the general Good of the Colony; unto which we promise all due Submission and Obedience.” He would go on to serve as the Governor of Plymouth Colony for over 30 years and would chronicle the beginning years Of Plymouth Plantation. He would also lose his wife as one of the first casualties of the hardships they had to endure on a daily basis. And if the life stories of John Smith and William Bradford aren’t sufficient to stir a sense of pride in the courage and commitment of our early forefathers, perhaps we should close with the advice of John Winthrop, the lawyer and the leader of the Puritans who would establish the Massachusetts Bay Colony in 1630. He reminded these Puritans that they were to be governed by the laws of their Creator. • By the first of these laws man as he was enabled so, withal is commanded to love his neighbour as himself. Upon this ground stands all the precepts of the moral law, which concerns our dealings with men. • Thus stands the cause between God and us. We are entered into Covenant with Him for this work. • the only way to avoid this shipwreck, and to provide for our posterity, is to follow the counsel of Micah, to do justly, to love mercy, to walk humbly with our God. • For we must consider that we shall be as a city upon a hill. The eyes of all people are upon us. So that if we shall deal falsely with our God in this work we have undertaken, and so cause him to withdraw his present help from us, we shall be made a story and a by-word through the world. • Therefore let us choose life that we, and our seed may live, by obeying His voice and cleaving to Him, for He is our life and our prosperity. We have much to be thankful for this Thanksgiving, including those who shared their religious faith in a land that Thomas Jefferson called the world’s best hope. Blanche Henderson Brick, Ph.D., retired Professor of History, Blinn College, Bryan, Texas. Blanchebrick@gmail.com

Yankees reportedly agree eight-year, $218 million deal with pitcher FriedStock market today: Wall Street slips to a rare back-to-back loss

WEST FARGO — When Happy, a sweet but oblivious-to-danger 9-year-old mare scraped up her back leg once again, owner Alicia Severson was able to call on Casselton Veterinary Service to visit her Gandin, N.D., farm and patch up Happy. But when it comes to a recurring ligament injury Happy sustained while competing in a barrel competition, Severson and many other horse and farm animal owners are finding it more difficult every year to find big animal veterinarians, and especially ones that specialize in certain care. ADVERTISEMENT "There is absolutely a shortage," Severson said. For decades, ranchers have been sounding the alarm about a shortage of rural veterinarians and new big animal vets, and especially those who specialize in caring for horses, cows, pigs and sheep. The problem persists despite land grant universities such as North Dakota State University, who often send undergraduates interested in the profession to far-away schools for continuing education. According to the U.S. Department of Agriculture , 500 counties across 46 states reported critical shortages of big animal vets. And while large animal veterinarians have long been a challenge to find in rural areas, where they are most needed, veterinarians who specialize in horses are also waning. That's despite the increasing popularity and availability in North Dakota and Minnesota for younger generations to compete in equine activities. According to an online database, about 43,200 horses call North Dakota home, which is about one horse per 18 people in the state. Leon Glasser, president of the North Dakota Quarter Horse Racing Association, has been breeding, raising and racing horses for more than 40 years, working to improve the quality of racehorses born in North Dakota. Over the years, he's watched the number of veterinarians willing to work with horses dwindle quickly. "Are we short of equine vets in this area? Absolutely, we are," Glasser said. He said a veterinary clinic in New Salem, N.D., will now only provide simple paperwork needed for owners to transport horses across state lines for care and Missouri Valley Vet Clinic in Bismarck has also limited equine services in the same way. Most newer veterinarians prefer to work on dogs and cats exclusively, he said. ADVERTISEMENT Severson agreed, noting it is also difficult to find a veterinarian who has experience treating goats, as the Seversons have two goats at their farm along with the horses and a cat. For Happy's ligament issue, of which she's had recurring surgeries and needs sporadic treatment, Severson worked with an equine sports medicine specialist based in the Twin Cities but would travel into western Minnesota. However, that veterinarian recently retired, leaving Severson on the hunt to find another specialist within a few hundred miles of the Red River Valley. "Nothing takes the place of a seasoned veterinarian," Severson said. "Thankfully, Casselton [Veterinary Service] is fabulous when it comes to when my horse is injured. But when it comes to long-term stuff that she's dealing with, it's difficult." Access to education and access to vets Dr. Alexa Weyer at Casselton Veterinary grew up in Snohomish, Wash., a farm town north of Seattle, and graduated with a bachelor's degree in biology from the University of North Dakota before finishing her doctorate in Veterinary Medicine at Auburn University in Alabama. Following graduation, she began working at Casselton Veterinary in early 2021. "There is definitely a shortage of people interested in large animal practice, and we would love to see more interest," Weyer said. To be a veterinarian requires a doctorate degree from a veterinary school or program accredited by the American Veterinary Medical Association and passing the North American Veterinary Licensing Exam, which is an extensive 360-question exam on all species (dogs, cats, horses, cows, goats, pigs, birds, reptiles, rabbits, fish and more) and all aspects of veterinary medicine. ADVERTISEMENT Veterinarians can choose to either go straight into general practice after graduation or they can seek further education to become a specialist. To be a veterinarian technician requires a two- or four-year veterinary technology degree, depending on the program. Derine Winning, a veterinarian at Valley Veterinary Hospital in Fargo and public policy adviser for the North Dakota Veterinary Medical Association, said the vast majority — about 70% — of new graduate veterinarians became companion animal practitioners in 2023. Almost 10% became mixed animal practitioners and only 6% became equine practitioners. The data comes from the American Veterinary Medical Association's 2024 Economic State of the Profession Report. "There are a lot of different areas in which veterinarians can become board certified through advanced education and training," Winning said. Animal specialists of any kind can be difficult to find locally, although Winning said the Red River Animal and Emergency Hospital and Referral Center in Fargo does have some specialists in oncology, surgery, internal medicine and emergency and critical care. Casselton Veterinary provides many large animal services from emergency on-call care to posting a doctor and technician for nights and weekends. In addition to their vets traveling to farms, the clinic has a large treatment area with two stocks and stalls for hospitalization and breeding care. The clinic also has several portable imaging tools. Weyer said the trend of vets moving away from rural areas can be seen in the growing need for referrals. "Unfortunately, most referral facilities across the country for large and small animals are in areas of high population density. For large animals, there are even fewer facilities and they tend to be at universities with veterinary schools or in areas of high equine concentration," she said. ADVERTISEMENT While the Casselton doctors work with a variety of places for specialty referrals, Sturgis Equine in western South Dakota and the University of Minnesota are probably most used by the clinic. Still, the closest drive is about four hours. Weyer said referrals are typically needed for colic surgery, arthroscopic surgery, advanced imaging or advanced hospitalizations. "In general practice like we are, there are always times to refer. For our clients, it would be nice to have a closer option, but a lot of areas in the country are even farther from referral than we are," Weyer said. Beth Carlson, deputy veterinarian with the North Dakota Department of Agriculture, said rural areas most in need of large animal veterinarians may not attract college graduates with those abilities. "The ratio of large animal veterinarians has shifted quite a bit," Carlson said. "Certainly there are areas of the state where it is difficult to hire veterinarians for a variety of reasons. In some cases it's challenging to hire veterinarians even in urban areas as well." One challenge is the cost of becoming a veterinarian. The USDA offers a program that provides up to $75,000 in veterinary school loan repayment to graduates who agree to work in underserved rural communities a minimum of three years. While some in Congress have recently proposed increasing that amount, it can still be daunting as new veterinarians, on average, face about $190,000 in school debt over the eight years needed to become a veterinarian. ADVERTISEMENT According to the American Veterinary Medicine Association, the mean starting salary for a veterinarian working predominantly in the treatment of food animals is about $85,000, but it was more than $100,000 for those who specialize in pet care. The North Dakota Department of Agriculture does work with residents interested in attending veterinary school. Carlson said her office assists with applications for veterinary loan repayment programs. "There are a few different ways that the state and federal government has approached that issue," Carlson said. While NDSU has a veterinarian technician program, there are currently no veterinary schools in North Dakota. In fact, there are only about 30 veterinary schools nationwide. The closest to North Dakota and some of the most renowned veterinary medicine schools are the University of Minnesota, University of Iowa and Kansas State. "NDSU is a great agricultural school and has a great veterinary technician program," Weyer said. "It might be nice to have a veterinary doctorate program at NDSU, but I am not sure that the population is there yet to support one."Joel Isaacson & Co. LLC Has $29.39 Million Stake in Amazon.com, Inc. (NASDAQ:AMZN)

THOUSAND OAKS, Calif. , Dec. 10, 2024 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that its Board of Directors declared a $2.38 per share dividend for the first quarter of 2025. The dividend will be paid on March 7, 2025 , to all stockholders of record as of the close of business on February 14, 2025 . About Amgen Amgen discovers, develops, manufactures and delivers innovative medicines to help millions of patients in their fight against some of the world's toughest diseases. More than 40 years ago, Amgen helped to establish the biotechnology industry and remains on the cutting-edge of innovation, using technology and human genetic data to push beyond what's known today. Amgen is advancing a broad and deep pipeline that builds on its existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases. In 2024, Amgen was named one of the "World's Most Innovative Companies" by Fast Company and one of "America's Best Large Employers" by Forbes, among other external recognitions . Amgen is one of the 30 companies that comprise the Dow Jones Industrial Average ® , and it is also part of the Nasdaq-100 Index ® , which includes the largest and most innovative non-financial companies listed on the Nasdaq Stock Market based on market capitalization. For more information, visit Amgen.com and follow Amgen on X , LinkedIn , Instagram , TikTok , YouTube and Threads . Forward-Looking Statements This news release contains forward-looking statements that are based on the current expectations and beliefs of Amgen. All statements, other than statements of historical fact, are statements that could be deemed forward-looking statements, including any statements on the outcome, benefits and synergies of collaborations, or potential collaborations, with any other company (including BeiGene, Ltd. or Kyowa Kirin Co., Ltd.), the performance of Otezla® (apremilast) (including anticipated Otezla sales growth and the timing of non-GAAP EPS accretion), our acquisitions of Teneobio, Inc., ChemoCentryx, Inc., or Horizon Therapeutics plc (including the prospective performance and outlook of Horizon's business, performance and opportunities, any potential strategic benefits, synergies or opportunities expected as a result of such acquisition, and any projected impacts from the Horizon acquisition on our acquisition-related expenses going forward), as well as estimates of revenues, operating margins, capital expenditures, cash, other financial metrics, expected legal, arbitration, political, regulatory or clinical results or practices, customer and prescriber patterns or practices, reimbursement activities and outcomes, effects of pandemics or other widespread health problems on our business, outcomes, progress, and other such estimates and results. Forward-looking statements involve significant risks and uncertainties, including those discussed below and more fully described in the Securities and Exchange Commission reports filed by Amgen, including our most recent annual report on Form 10-K and any subsequent periodic reports on Form 10-Q and current reports on Form 8-K. Unless otherwise noted, Amgen is providing this information as of the date of this news release and does not undertake any obligation to update any forward-looking statements contained in this document as a result of new information, future events or otherwise. No forward-looking statement can be guaranteed and actual results may differ materially from those we project. Our results may be affected by our ability to successfully market both new and existing products domestically and internationally, clinical and regulatory developments involving current and future products, sales growth of recently launched products, competition from other products including biosimilars, difficulties or delays in manufacturing our products and global economic conditions. In addition, sales of our products are affected by pricing pressure, political and public scrutiny and reimbursement policies imposed by third-party payers, including governments, private insurance plans and managed care providers and may be affected by regulatory, clinical and guideline developments and domestic and international trends toward managed care and healthcare cost containment. Furthermore, our research, testing, pricing, marketing and other operations are subject to extensive regulation by domestic and foreign government regulatory authorities. We or others could identify safety, side effects or manufacturing problems with our products, including our devices, after they are on the market. Our business may be impacted by government investigations, litigation and product liability claims. In addition, our business may be impacted by the adoption of new tax legislation or exposure to additional tax liabilities. If we fail to meet the compliance obligations in the corporate integrity agreement between us and the U.S. government, we could become subject to significant sanctions. Further, while we routinely obtain patents for our products and technology, the protection offered by our patents and patent applications may be challenged, invalidated or circumvented by our competitors, or we may fail to prevail in present and future intellectual property litigation. We perform a substantial amount of our commercial manufacturing activities at a few key facilities, including in Puerto Rico , and also depend on third parties for a portion of our manufacturing activities, and limits on supply may constrain sales of certain of our current products and product candidate development. An outbreak of disease or similar public health threat, such as COVID-19, and the public and governmental effort to mitigate against the spread of such disease, could have a significant adverse effect on the supply of materials for our manufacturing activities, the distribution of our products, the commercialization of our product candidates, and our clinical trial operations, and any such events may have a material adverse effect on our product development, product sales, business and results of operations. We rely on collaborations with third parties for the development of some of our product candidates and for the commercialization and sales of some of our commercial products. In addition, we compete with other companies with respect to many of our marketed products as well as for the discovery and development of new products. Discovery or identification of new product candidates or development of new indications for existing products cannot be guaranteed and movement from concept to product is uncertain; consequently, there can be no guarantee that any particular product candidate or development of a new indication for an existing product will be successful and become a commercial product. Further, some raw materials, medical devices and component parts for our products are supplied by sole third-party suppliers. Certain of our distributors, customers and payers have substantial purchasing leverage in their dealings with us. The discovery of significant problems with a product similar to one of our products that implicate an entire class of products could have a material adverse effect on sales of the affected products and on our business and results of operations. Our efforts to collaborate with or acquire other companies, products or technology, and to integrate the operations of companies or to support the products or technology we have acquired, may not be successful. There can be no guarantee that we will be able to realize any of the strategic benefits, synergies or opportunities arising from the Horizon acquisition, and such benefits, synergies or opportunities may take longer to realize than expected. We may not be able to successfully integrate Horizon, and such integration may take longer, be more difficult or cost more than expected. A breakdown, cyberattack or information security breach of our information technology systems could compromise the confidentiality, integrity and availability of our systems and our data. Our stock price is volatile and may be affected by a number of events. Our business and operations may be negatively affected by the failure, or perceived failure, of achieving our environmental, social and governance objectives. The effects of global climate change and related natural disasters could negatively affect our business and operations. Global economic conditions may magnify certain risks that affect our business. Our business performance could affect or limit the ability of our Board of Directors to declare a dividend or our ability to pay a dividend or repurchase our common stock. We may not be able to access the capital and credit markets on terms that are favorable to us, or at all. CONTACT: Amgen, Thousand Oaks Elissa Snook , 609-251-1407 (media) Justin Claeys , 805-313-9775 (investors) View original content to download multimedia: https://www.prnewswire.com/news-releases/amgen-announces-2025-first-quarter-dividend-302328180.html SOURCE Amgen

Handshakes and hugs as Cardin bids Senate farewell: ‘He put substance over flash’

Equinor ASA ( NYSE:EQNR – Get Free Report ) was downgraded by stock analysts at StockNews.com from a “strong-buy” rating to a “buy” rating in a research note issued to investors on Thursday. EQNR has been the topic of a number of other reports. Citigroup raised Equinor ASA to a “strong sell” rating in a report on Wednesday, October 2nd. UBS Group raised shares of Equinor ASA from a “sell” rating to a “neutral” rating in a research note on Thursday, August 8th. Morgan Stanley raised shares of Equinor ASA from an “underweight” rating to an “equal weight” rating and set a $25.80 price target for the company in a research note on Monday, October 14th. Redburn Atlantic upgraded shares of Equinor ASA from a “neutral” rating to a “buy” rating in a research note on Wednesday. Finally, Barclays raised Equinor ASA to a “hold” rating in a report on Wednesday, October 2nd. Two analysts have rated the stock with a sell rating, six have issued a hold rating and three have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $26.90. Check Out Our Latest Report on Equinor ASA Equinor ASA Stock Performance Equinor ASA ( NYSE:EQNR – Get Free Report ) last issued its earnings results on Thursday, October 24th. The company reported $0.79 earnings per share for the quarter, topping the consensus estimate of $0.74 by $0.05. Equinor ASA had a return on equity of 19.97% and a net margin of 8.95%. The firm had revenue of $25.45 billion for the quarter, compared to analyst estimates of $24.45 billion. During the same period last year, the company earned $0.92 earnings per share. As a group, analysts anticipate that Equinor ASA will post 3.31 EPS for the current year. Institutional Inflows and Outflows A number of institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Atwood & Palmer Inc. purchased a new position in Equinor ASA in the second quarter valued at about $25,000. Reston Wealth Management LLC acquired a new stake in shares of Equinor ASA during the 3rd quarter valued at about $31,000. Rothschild Investment LLC bought a new stake in shares of Equinor ASA in the 2nd quarter valued at approximately $32,000. EverSource Wealth Advisors LLC increased its holdings in Equinor ASA by 27.1% in the second quarter. EverSource Wealth Advisors LLC now owns 1,712 shares of the company’s stock worth $45,000 after buying an additional 365 shares during the last quarter. Finally, Bruce G. Allen Investments LLC raised its position in Equinor ASA by 363.5% during the third quarter. Bruce G. Allen Investments LLC now owns 1,928 shares of the company’s stock valued at $49,000 after acquiring an additional 1,512 shares in the last quarter. 5.51% of the stock is owned by hedge funds and other institutional investors. Equinor ASA Company Profile ( Get Free Report ) Equinor ASA, an energy company, engages in the exploration, production, transportation, refining, and marketing of petroleum and other forms of energy in Norway and internationally. It operates through Exploration & Production Norway; Exploration & Production International; Exploration & Production USA; Marketing, Midstream & Processing; Renewables; and Other segments. See Also Receive News & Ratings for Equinor ASA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Equinor ASA and related companies with MarketBeat.com's FREE daily email newsletter .